Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$30.0M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Insufficient data. Current ROIC on all capital: -19%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $801.0M is below the $1.18B due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.” Effective rate ~7.5% on $5.94B of debt.
Cash of $801.0M is below short-term debt of $870.0M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
The most recent twelve months of free cash flow. Most current, and the most exposed to one quarter of working-capital timing.
To be worth $4.29 today, the market must believe free cash flow compounds 14.6%/yr for a decade (off $192.0M on the TTM basis).
Default is the published 10.0% — this company's own cost of capital could not be computed.
2-stage DCF · 0.29B shares (market data) · net debt $5.14B
mean -106.5% · volatility σ 356% · implied rate exceeded in 1/6 yrs
Central path = implied 14.6%/yr growth; shaded band = ±1σ (356%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-10-30
Where each multiple sits in its own 14-yr range · 0th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE -53% against ROIC -19% — -34% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is -43.5% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 77.3 | 78.7 | 83.9 | 78.3 | 81.5 | 82.6 | 80.5 | 81.6 |
| R&D | 2.7 | 2.9 | 3.2 | 2.7 | 2.4 | 2.3 | 2.3 | 2.1 |
| SG&A | 14.9 | 15.8 | 17.8 | 15.4 | 13.4 | 14.0 | 14.7 | 14.9 |
| Income Tax | 2.0 | 3.2 | 0.9 | -1.5 | 0.9 | 0.0 | 0.5 | 8.6 |
| Net Income | 4.5 | -2.1 | -10.2 | 4.4 | 0.9 | -3.6 | 0.2 | -9.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on GT: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.28B 100.0% | $18.88B 100.0% | $20.07B 100.0% | $20.80B 100.0% | $17.48B 100.0% | $12.32B 100.0% | $14.74B 100.0% | $15.47B 100.0% | $15.38B 100.0% | $15.16B 100.0% |
| Cost of Revenue | $14.91B 81.6% | $15.19B 80.5% | $16.58B 82.6% | $16.95B 81.5% | $13.69B 78.3% | $10.34B 83.9% | $11.60B 78.7% | $11.96B 77.3% | $11.68B 76.0% | $10.94B 72.1% |
| Cost of Products | — | — | — | — | — | — | — | — | $11.72B 76.2% | $10.97B 72.4% |
| Research & Development | $380.0M 2.1% | $426.0M 2.3% | $461.0M 2.3% | $501.0M 2.4% | $473.0M 2.7% | $390.0M 3.2% | $430.0M 2.9% | $424.0M 2.7% | $406.0M 2.6% | $388.0M 2.6% |
| Selling, General & Admin | $2.72B 14.9% | $2.78B 14.7% | $2.81B 14.0% | $2.80B 13.4% | $2.70B 15.4% | $2.19B 17.8% | $2.32B 15.8% | $2.31B 14.9% | $2.28B 14.8% | $2.41B 15.9% |
| Interest Expense | $445.0M 2.4% | $522.0M 2.8% | $532.0M 2.7% | $451.0M 2.2% | $387.0M 2.2% | $324.0M 2.6% | $340.0M 2.3% | $321.0M 2.1% | $335.0M 2.2% | $372.0M 2.5% |
| Interest & Investment Income | $37.0M 0.2% | $54.0M 0.3% | $84.0M 0.4% | $34.0M 0.2% | $24.0M 0.1% | $14.0M 0.1% | $18.0M 0.1% | $16.0M 0.1% | $13.0M 0.1% | $15.0M 0.1% |
| Other Income (Expense), net | -$288.0M -1.6% | -$134.0M -0.7% | -$231.0M -1.2% | -$209.0M -1.0% | -$94.0M -0.5% | -$119.0M -1.0% | $98.0M 0.7% | $174.0M 1.1% | -$70.0M -0.5% | -$25.0M -0.2% |
| Pretax Income | -$133.0M -0.7% | $130.0M 0.7% | -$721.0M -3.6% | $399.0M 1.9% | $513.0M 2.9% | -$1.14B -9.3% | $177.0M 1.2% | $1.01B 6.5% | $878.0M 5.7% | $1.21B 8.0% |
| Income Tax Expense | $1.57B 8.6% | $95.0M 0.5% | $10.0M 0.0% | $190.0M 0.9% | -$267.0M -1.5% | $110.0M 0.9% | $474.0M 3.2% | $303.0M 2.0% | $513.0M 3.3% | -$77.0M -0.5% |
| Net Income | -$1.72B -9.4% | $46.0M 0.2% | -$729.0M -3.6% | $191.0M 0.9% | $764.0M 4.4% | -$1.25B -10.2% | -$311.0M -2.1% | $693.0M 4.5% | $346.0M 2.3% | $1.26B 8.3% |
| Per Share | ||||||||||
| EPS (Basic) | -$5.99 | $0.16 | -$2.56 | $0.67 | $2.92 | -$5.35 | -$1.33 | $2.92 | $1.39 | $4.81 |
| EPS (Diluted) | -$5.99 | $0.16 | -$2.56 | $0.67 | $2.89 | -$5.35 | -$1.33 | $2.89 | $1.37 | $4.74 |
| Weighted Avg Shares (Basic) | 288.0M | 287.0M | 285.0M | 284.0M | 261.0M | 234.0M | 233 | 237.0M | 249.0M | 263.0M |
| Weighted Avg Shares (Diluted) | 288.0M | 288.0M | 285.0M | 286.0M | 264.0M | 234.0M | 233 | 239.0M | 253.0M | 266.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Ranked against 14 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NKE | $57.1B | 18.3× | 12.6× | 1.2× | 0.2% | 42.9% | 6.7% | 20.9% | 13.6% | 0.1× | 490 |
| ENTG | $24.4B | 103.2× | 42.0× | 7.7× | -1.4% | 44.4% | 7.4% | 6.0% | 3.1% | 5.0× | 182 |
| CSL | $14.7B | 21.7× | 13.8× | 2.9× | 0.3% | 35.7% | 14.8% | 41.3% | 15.8% | 1.5× | 185 |
| DECK | $11.3B | 11.8× | 7.0× | 2.1× | 9.8% | 57.7% | 18.7% | 41.0% | 41.0% | -1.4× | 202 |
| WMS | $10.3B | 25.1× | 15.1× | 3.4× | 5.0% | 38.3% | 14.0% | 22.9% | 12.3% | 1.8× | 133 |
| ATR | $8.3B | 22.2× | 11.7× | 2.2× | 5.4% | — | 10.4% | 14.7% | 9.8% | 1.2× | 131 |
| CROX | $7.2B | — | 36.3× | 1.8× | -1.5% | 58.3% | -2.0% | -6.3% | -3.2% | 4.8× | 96 |
| AWI | $6.9B | 23.4× | 13.1× | 4.3× | 12.1% | 40.6% | 19.0% | 34.3% | 23.6% | 0.5× | 98 |
| NPO | $6.0B | 148.9× | 24.8× | 5.3× | 9.0% | 42.6% | 3.5% | 2.6% | 1.8% | 2.0× | 87 |
| NWL | $2.2B | — | 18.9× | 0.3× | -5.0% | 33.8% | -4.0% | -11.9% | -4.0% | 12.8× | 83 |
| GT | $1.3B | — | — | 0.1× | -3.2% | 18.4% | -9.4% | -53.2% | -18.8% | — | 74 |
| MYE | $1.1B | 32.7× | 15.7× | 1.4× | -1.3% | 33.4% | 4.2% | 11.9% | 5.5% | 3.3× | 29 |
| KRT | $1.1B | 34.9× | 20.3× | 2.3× | 10.7% | 36.8% | 6.7% | 21.1% | 19.4% | -0.5× | 29 |
| SWIM | $854M | 80.7× | 13.0× | 1.6× | 7.4% | 33.4% | 2.0% | 2.7% | 1.6% | 2.5× | 20 |
| CMT | $199M | 17.5× | 6.8× | 0.7× | -9.5% | 17.4% | 4.1% | 7.1% | 6.3% | -0.7× | 11 |
Peers = companies sharing GT's sector (Tires & Inner Tubes) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 27.9% | not reported | 8.3% |
| FY2017 | 24.0% | not reported | 2.3% |
| FY2018 | 22.7% | not reported | 4.5% |
| FY2019 | 21.3% | not reported | -2.1% |
| FY2020 | 16.1% | not reported | -10.2% |
| FY2021 | 21.7% | not reported | 4.4% |
| FY2022 | 18.5% | not reported | 0.9% |
| FY2023 | 17.4% | not reported | -3.6% |
| FY2024 | 19.5% | not reported | 0.2% |
| FY2025 | 18.4% | not reported | -9.4% |
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Return on equity is 34 points BELOW the return on invested capital, which means the equity base is carrying capital the operations are not earning on — usually cash, goodwill, or a recent raise.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
Free cash flow has fallen short of reported profit in 3 of the last three years.
| Step | Amount | Running total |
|---|---|---|
| Net income | −$1.72B | −$1.72B |
| Share-based comp | $23M | −$1.70B |
| Other non-cash & working capital | $2.49B | $796M |
| Operating cash flow | $796M | $796M |
| Capex | −$826M | −$30M |
| Free cash flow | −$30M | −$30M |
| FCF after SBC | −$53M | −$53M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | -16.4% | -12.9% | 3.6 points |
| FY2021 | 41.9% | 41.2% | -0.7 points |
| FY2022 | 19.0% | 9.3% | -9.7 points |
| FY2023 | -3.5% | 4.6% | 8.2 points |
| FY2024 | -5.9% | -9.1% | -3.2 points |
| FY2025 | -3.2% | -5.7% | -2.5 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 48 days | 89.7 days | 91.5 days | 46.3 days |
| FY2020 | 50.1 days | 76 days | 104 days | 22.1 days |
| FY2021 | 49.8 days | 95.8 days | 110.6 days | 35.1 days |
| FY2022 | 45.8 days | 98.4 days | 103.4 days | 40.8 days |
| FY2023 | 49.7 days | 80.8 days | 95.9 days | 34.6 days |
| FY2024 | 48 days | 85.4 days | 98.3 days | 35.1 days |
| FY2025 | 46.7 days | 87.4 days | 95 days | 39.2 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | -8.8 percent |
| FY2020 | -14.3 percent |
| FY2021 | -1.4 percent |
| FY2022 | -1.5 percent |
| FY2023 | -8.2 percent |
| FY2024 | -3.1 percent |
| FY2025 | -13.8 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 1 year to the latest.
Reported free cash flow is -$30M; after share-based compensation it is -$53M. The difference is a real cost that the cash flow statement adds back.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
Ladder as of 2025-12-31 (10-K); cash from the 2025-12-31 balance sheet; FCF from FY2025. Free cash flow is negative, so projected resources fall rather than accumulate.
Balance sheet at 2025-12-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: ebitda.
No positive free cash flow to discount, so the price cannot be expressed as a growth requirement.
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).
Missing from our data, so excluded from this answer: free_cash_flow.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Winkler Jason J Director | Grant | 6,958 | $5.03 | — |
| 2026-09-01 | 3 co-filers Man. Dir. EMEA & CSO | Option exercise | 12,775 | $0.00 | $0 |
| 2026-09-01 | 3 co-filers Man. Dir. EMEA & CSO | Tax withholding | 6,324 | $5.99 | $38k |
| 2026-09-01 | 3 co-filers Man. Dir. EMEA & CSO | Option exercise | 12,775 | $0.00 | — |
| 2026-07-01 |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.
| Grant |
| 23,219 |
| $0.00 |
| — |
| 2026-07-01 | Winkler Jason J Director | Grant | 5,417 | $6.46 | — |
| 2026-07-01 | 3 co-filers Senior VP & Chief HR Officer | Option exercise | 5,114 | $0.00 | $0 |
| 2026-07-01 | Deakin Scott M Interim EVP & CFO | Grant | 77,399 | $0.00 | — |
| 2026-07-01 | 3 co-filers Senior VP & Chief HR Officer | Tax withholding | 2,281 | $6.46 | $15k |
| 2026-07-01 | 3 co-filers Senior VP & Chief HR Officer | Option exercise | 5,114 | $0.00 | — |
| 2026-05-15 | 3 co-filers Senior VP, Global Commercial | Option exercise | 3,170 | $0.00 | $0 |
| 2026-05-15 | 3 co-filers CEO & President | Option exercise | 355,537 | $0.00 | $0 |
| 2026-05-15 | 3 co-filers Senior VP, Global Commercial | Tax withholding | 2,111 | $5.64 | $12k |
| 2026-05-15 | 3 co-filers CEO & President | Tax withholding | 163,903 | $5.64 | $924k |
| 2026-05-15 | 3 co-filers Senior VP, Global Commercial | Option exercise | 3,170 | $0.00 | — |
| 2026-05-15 | 3 co-filers CEO & President | Option exercise | 355,537 | $0.00 | — |
| 2026-04-13 | Hinrichs Joseph R Director | Grant | 25,605 | $7.03 | — |
| 2026-04-13 | 3 co-filers Group filing | Option exercise | 19,047 | $0.00 | $0 |
| 2026-04-13 | Wood Roger Director | Grant | 25,605 | $7.03 | — |
| 2026-04-13 | Mitchell Max H Director | Grant | 25,605 | $7.03 | — |
| 2026-04-13 | 3 co-filers Group filing | Option exercise | 9,523 | $0.00 | $0 |
| 2026-04-13 | 3 co-filers Group filing | Option exercise | 19,047 | $0.00 | $0 |
| 2026-04-13 | Hamilton Julie Director | Grant | 25,605 | $7.03 | — |
| 2026-04-13 | Koellner Laurette T Director | Grant | 25,605 | $7.03 | — |
| 2026-04-13 | Wessel Michael Director | Grant | 25,605 | $7.03 | — |
| 2026-04-13 | 3 co-filers Group filing | Option exercise | 19,047 | $0.00 | $0 |
| 2026-04-13 | 2 co-filers Group filing | Grant | 12,802 | $7.03 | — |
| 2026-04-13 | Clayton Norma Director | Grant | 25,605 | $7.03 | — |
| 2026-04-13 | 2 co-filers Group filing | Grant | 12,802 | $7.03 | — |
| 2026-04-13 | 3 co-filers Group filing | Option exercise | 9,523 | $0.00 | — |
| 2026-04-13 | 3 co-filers Group filing | Tax withholding | 4,572 | $7.03 | $32k |
| 2026-04-13 | 3 co-filers Group filing | Option exercise | 19,047 | $0.00 | — |
| 2026-04-13 | 3 co-filers Group filing | Option exercise | 19,047 | $0.00 | — |
| 2026-04-13 | 3 co-filers Group filing | Grant | 25,605 | $7.03 | — |
| 2026-04-13 | 3 co-filers Group filing | Grant | 25,605 | $7.03 | — |
| 2026-04-13 | 3 co-filers Group filing | Grant | 25,605 | $7.03 | — |
| 2026-04-13 | 3 co-filers Group filing | Option exercise | 19,047 | $0.00 | — |
| 2026-04-01 | Winkler Jason J Director | Grant | 5,216 | $6.71 | — |
| 2026-03-31 | 3 co-filers Vice President and Controller | Option exercise | 6,805 | $0.00 | $0 |
| 2026-03-31 | 3 co-filers Vice President and Controller | Tax withholding | 3,073 | $6.63 | $20k |